Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging

Overview of attention for article published in Aging, March 2011

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 517 Dimensions

Readers on

mendeley: 593 Mendeley
citeulike: 1 CiteULike

Summary Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

S6K1 protein kinase inhibitors as cancer therapeutics

Grant US-11912660-B2

United States of America

Extracts of Curcuma amada and uses thereof

Grant US-10568925-B2

United States of America

Companion diagnostic for CDK4 inhibitors

Grant US-9889135-B2

United States of America

Isoindolinone and pyrrolopyridinone derivatives as Akt inhibitors

Grant US-8895571-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.